These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 7913275)
1. NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line. Antoni BA; Rabson AB; Kinter A; Bodkin M; Poli G Virology; 1994 Aug; 202(2):684-94. PubMed ID: 7913275 [TBL] [Abstract][Full Text] [Related]
2. Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-kappa B. Laughlin MA; Chang GY; Oakes JW; Gonzalez-Scarano F; Pomerantz RJ J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(4):332-9. PubMed ID: 7600100 [TBL] [Abstract][Full Text] [Related]
3. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. Finnegan A; Roebuck KA; Nakai BE; Gu DS; Rabbi MF; Song S; Landay AL J Immunol; 1996 Jan; 156(2):841-51. PubMed ID: 8543841 [TBL] [Abstract][Full Text] [Related]
4. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function. Kameoka M; Tanaka Y; Ota K; Itaya A; Yoshihara K Biochem Biophys Res Commun; 1999 Aug; 262(1):285-9. PubMed ID: 10448106 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770 [TBL] [Abstract][Full Text] [Related]
6. Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kappaB-dependent pathway. Sun J; Bergeron M; Barbeau B; Boivin G; Tremblay MJ Clin Immunol; 2005 Feb; 114(2):190-8. PubMed ID: 15639653 [TBL] [Abstract][Full Text] [Related]
7. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447 [TBL] [Abstract][Full Text] [Related]
8. Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. Israël N; Gougerot-Pocidalo MA; Aillet F; Virelizier JL J Immunol; 1992 Nov; 149(10):3386-93. PubMed ID: 1431113 [TBL] [Abstract][Full Text] [Related]
9. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals. Tong-Starksen SE; Welsh TM; Peterlin BM J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623 [TBL] [Abstract][Full Text] [Related]
10. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages. Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233 [TBL] [Abstract][Full Text] [Related]
11. An increase in p50/p65 NF-kB binding to the HIV-1 LTR is not sufficient to increase viral expression in the primary human astrocyte. Conant K; Atwood WJ; Traub R; Tornatore C; Major EO Virology; 1994 Dec; 205(2):586-90. PubMed ID: 7975262 [TBL] [Abstract][Full Text] [Related]
12. Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-kappa B DNA binding proteins. Qian J; Bours V; Manischewitz J; Blackburn R; Siebenlist U; Golding H J Immunol; 1994 Apr; 152(8):4183-91. PubMed ID: 8144979 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockade of the human 55-kDa TNF receptor. Kruppa G; Thoma B; Machleidt T; Wiegmann K; Krönke M J Immunol; 1992 May; 148(10):3152-7. PubMed ID: 1315830 [TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. Israël N; Hazan U; Alcami J; Munier A; Arenzana-Seisdedos F; Bachelerie F; Israël A; Virelizier JL J Immunol; 1989 Dec; 143(12):3956-60. PubMed ID: 2574206 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR. Harhaj E; Blaney J; Millhouse S; Sun SC Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004 [TBL] [Abstract][Full Text] [Related]
16. Effects of CD45 on NF-kappa B. Implications for replication of HIV-1. Baur A; Garber S; Peterlin BM J Immunol; 1994 Feb; 152(3):976-83. PubMed ID: 7905504 [TBL] [Abstract][Full Text] [Related]
17. NF- kappa B independent suppression of endothelial vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 gene expression by inhibition of flavin binding proteins and superoxide production. Tummala PE; Chen XL; Medford RM J Mol Cell Cardiol; 2000 Aug; 32(8):1499-508. PubMed ID: 10900176 [TBL] [Abstract][Full Text] [Related]
18. Induction of nuclear factor-kappa B and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A. Thévenin C; Kim SJ; Rieckmann P; Fujiki H; Norcross MA; Sporn MB; Fauci AS; Kehrl JH New Biol; 1990 Sep; 2(9):793-800. PubMed ID: 2177654 [TBL] [Abstract][Full Text] [Related]
19. The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements. Bernier R; Barbeau B; Tremblay MJ; Olivier M J Immunol; 1998 Mar; 160(6):2881-8. PubMed ID: 9510191 [TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. Moriuchi H; Moriuchi M; Fauci AS J Immunol; 1997 Apr; 158(7):3483-91. PubMed ID: 9120310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]